A comprehensive pharmacokinetic/pharmacodynamics analysis of the novel IGF1R/INSR inhibitor BI 893923 applying in vitro, in vivo and in silico modeling techniques
Crossref DOI link: https://doi.org/10.1007/s00280-016-3049-z
Published Online: 2016-05-09
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Titze, Melanie I.
Schaaf, Otmar
Hofmann, Marco H.
Sanderson, Michael P.
Zahn, Stephan K.
Quant, Jens
Lehr, Thorsten
Text and Data Mining valid from 2016-05-09